A special CBS2025 opportunity for ECR faculty members!
0 comments
by Lindsay Fitzpatrick
Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...
CBS2025 Final Abstract Submission Deadline Extension
0 comments
by
CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...
Abstract Deadline Extended to January 30th!
0 comments
by
Abstract deadline extended We are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until January 30th, 2025 The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...
Patients treated with radiotherapy for head and neck cancer and patients with Sj gren s syndrome experience decreased saliva flow due to the loss of salivary gland SG acinar cells...
Improved Properties of 3D Printed Nanocomposite Biomaterials Composed of Functionalized Biopolymers and Calcium-Deficient Hydroxyapatite Nanoparticles
comments
3D printable bio-based nanocomposites are a promising material for biomedical applications, such as in dentistry, skeletal reconstruction, and sustainable rapid prototyping 1 2 ...
Investigating the response of human dermal and gingival fibroblasts to changes in substratum compliance: Implications for soft tissue biomaterials development.
comments
Development of biomaterials for regeneration of soft tissues still faces critical challenges related to control of cell phenotype and the prevention of contraction scar tissue formation upon implantation...
The clinical use of 7-ethyl-10-hydroxy-camptothecin SN-38 , the active metabolite of irinotecan, has been hampered because of its practical water-insolubility...
Hair loss is a common disorder in humans due to a lot of reasons, in spite of life-threatening, it has impact on social interaction and psychological conditions, which in turn increases the demand for therapeutic treatment...
